Sage Journals: Discover world-class research

Retricted access

Review article

First published 2024-11

The Oncological Stress Test of Neoadjuvant Therapy: A Systematic Review in Outcomes of Neoadjuvant Therapy Compared to Upfront Resection Approach for Borderline Resectable Pancreatic Adenocarcinoma

Sharona B. Ross, Jesse Popover, Iswanto Sucandy [...]

The American Surgeon™

Retricted access

Research article

First published 2021

Predicting Surgical Margins in Patients With Borderline Resectable and Locally Advanced Pancreatic Cancer Undergoing Resection

Weizheng Ren, Dimitrios Xourafas, Stanley W. Ashley [...]

The American Surgeon™

Open access

Research article

First published 2020

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma

Changhoon Yoo, Inhwan Hwang, Tae Jun Song [...]

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2008-10

Borderline Resectable Pancreatic Cancer: On the Edge of Survival

Gregory M. Springett, Sarah E. Hoffe

Cancer Control

Open access

Research article

First published 2017-12

Multimodality Management of “Borderline Resectable” Pancreatic Neuroendocrine Tumors

Chenwi M. Ambe, Phuong Nguyen, Barbara A. Centeno [...]

Cancer Control

Open access

Research article

First published 2025

Impact of Preoperative Chemotherapy on Physical Function in Patients With Borderline Resectable Pancreatic Cancer: A Retrospective Study

Ken Kouda, Makoto Asaeda, Yuki Nakashima [...]

Integrative Cancer Therapies

Open access

Review article

First published 2021

Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma

Siddharth Iyengar, Christopher Nevala-Plagemann, Ignacio Garrido-Laguna

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2021

Prognostic Factors in Patients With Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Resection

Weizheng Ren, Dimitrios Xourafas, Stanley W. Ashley [...]

The American Surgeon™

Retricted access

Research article

First published 2025-1

Prognostic Impact of a Decrease in Serum Carbohydrate Antigen 19-9 Levels After Preoperative Therapy for 4 Months or More for Borderline Resectable Pancreatic Cancer Abutting Major Arteries

Michinori Matsumoto, Masashi Tsunematsu, Kyohei Abe [...]

The American Surgeon™

Retricted access

Research article

First published 2024-11

Neoadjuvant Chemotherapy and Radiation Improves Recurrence-free and Overall Survival in Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma

Jesse K. Kelley, Hordur Kolbeinsson, Sreenivasa Chandana [...]

The American Surgeon™

Search results